ATS 2024 Final Program

Click on the session title to view the speakers

283

TUESDAY • MAY 21

P183 Implications of High Oxygen Treatment on Healthy Airways and the Impact of Oxidative Processes P184 An AI-driven CT Biomarker of Airway Morphology for Monitoring Regional Changes in Pediatric Cystic Fibrosis

BASIC • CLINICAL • TRANSLATIONAL THEMATIC POSTER SESSION

C74 CYSTIC FIBROSIS AND NON-CF BRONCHIECTASIS 9:15 a.m. - 4:15 p.m.

San Diego Convention Center Area B (Hall A-B2, Ground Level)

CLINICAL • TRANSLATIONAL THEMATIC POSTER SESSION

Viewing: Posters will be on display for entire session Discussion: 11:30-12:30 Discussionwith facilitators, authors, andattendees 12:30-1:15 Authorswill beby their posters for individual discussionwithattendeesill bepresent for discussionwith assigned facilitators. P173 Individuals With CF Lung Disease Segregated by Severity With Xenon Ventilation MRI Display Divergent Molecular Signatures of Respiratory Tract Disease P174 Xe MRI Reveals Regional Gas-exchange Abnormalities in Cystic Fibrosis Lung Disease P175 Baseline Data From the Phase 2 Airleaf™ Trial of the Novel Cathepsin C Inhibitor BI 1291583 in Adult Patients With Bronchiectasis P176 Evaluation of Open-source Ciliary Analysis Software in Primary Ciliary Dyskinesia: A Comparative Assessment P177 Abnormal Sweat Chloride in Non-Cystic Fibrosis Bronchiectasis P178 Fully Automatic Assessment of Bronchus-Artery Dimensions and Ratios, Mucus Plugs, and Low Attenuation Regions in Cystic Fibrosis Patients Before and After Elexacaftor-Tezacaftor-Ivacaftor P179 Quantification of Lung Disease Severity in Cystic Fibrosis Using Z-scores: A Retrospective Cohort Study P180 EIT Images of Ventilation and Perfusion Correlate With Spirometry in Patients With Cystic Fibrosis and Healthy Controls P181 Males With Cystic Fibrosis Have Larger Central Airway Luminal Areas Than Females P182 Conducting Airway Luminal Area Is Greater in Individuals With Cystic Fibrosis Versus Healthy Controls: A Retrospective Analysis

C75 STRUCTURAL AND FUNCTIONAL CONSEQUENCES OF COVID 9:15 a.m. - 4:15 p.m. Viewing: Posters will be on display for entire session Discussion: 11:30-12:30 Discussionwith facilitators, authors, andattendees 12:30-1:15 Authorswill beby their posters for individual discussionwithattendees P186 Quantitative Characterization of Regional Ventilation and Perfusion in Patients With Persistent COVID-19 Symptoms Using Hyperpolarized 129 Xe MRI and Dual Energy CT P187 Single Breath Diffusing Capacity of the Lungs for Carbon Monoxide and Nitric Oxide in Patients With Persistent Symptoms After COVID Infection P188 Functional Status, Quality of Life and Lung Function of People Living With HIV With Post-acute COVID-19 Sequelae After 2 Years of Acute Disease: A Descriptive Study in the Western Brazilian Amazon, Brazil P189 Can Obesity Influence the Response of Muscle Oxygenation Kinetics in Long COVID-19 Patients? P190 Quantitative Computed Tomography Based Cluster Informed Assessment of Airway Resistance and Particle Deposition in Post-COVID-19 Lungs P191 St. George’s Respiratory Questionnaire (SGRQ) Based Cluster Analysis of Post-acute COVID-19 Sequelae P192 Longitudinal Analysis of Cytokine Profiles and Pulmonary Function in Post-acute Sequelae of SAR-CoV-2 (PASC) Patients San Diego Convention Center Area B (Hall A-B2, Ground Level)

ATS 2024 Conference Program • San Diego, CA